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Alkanols inhibit voltage-gated 
K+ channels via a distinct gating 
modifying mechanism that 
prevents gate opening
Evelyn Martínez-Morales, Ivan Kopljar†, Dirk J. Snyders & Alain J. Labro
Alkanols are small aliphatic compounds that inhibit voltage-gated K+ (Kv) channels through a 
yet unresolved gating mechanism. Kv channels detect changes in the membrane potential with 
their voltage-sensing domains (VSDs) that reorient and generate a transient gating current. 
Both 1-Butanol (1-BuOH) and 1-Hexanol (1-HeOH) inhibited the ionic currents of the Shaker 
Kv channel in a concentration dependent manner with an IC50 value of approximately 50 mM 
and 3 mM, respectively. Using the non-conducting Shaker-W434F mutant, we found that both 
alkanols immobilized approximately 10% of the gating charge and accelerated the deactivating 
gating currents simultaneously with ionic current inhibition. Thus, alkanols prevent the final VSD 
movement(s) that is associated with channel gate opening. Applying 1-BuOH and 1-HeOH to the 
Shaker-P475A mutant, in which the final gating transition is isolated from earlier VSD movements, 
strengthened that neither alkanol affected the early VSD movements. Drug competition experiments 
showed that alkanols do not share the binding site of 4-aminopyridine, a drug that exerts a similar 
effect at the gating current level. Thus, alkanols inhibit Shaker-type Kv channels via a unique gating 
modifying mechanism that stabilizes the channel in its non-conducting activated state.
Alkanols (or 1-alcohols) are small volatile aliphatic compounds that partition rapidly across the plasma 
membrane and have the potential to induce anesthesia at high doses1. Alkanols have been shown to 
target both cytoplasmic and plasma membrane proteins2,3, including voltage-gated K+ (Kv) channels4. Kv 
channels play an important role in cellular excitability as they constitute the cell’s repolarizing power; 
they shape the action potential duration and help setting the threshold for initiating one.
Kv channels are assembled from four α -subunits, each containing six transmembrane segments 
(S1–S6) whereby the S5–S6 segments create the K+ pore5. K+ flow through this pore is controlled by a 
channel gate that is located in the lower carboxyl-terminal part of S6 (S6c)6. Via an electromechanical 
coupling, composed of the S4–S5 linker and S6c, opening and closure of the channel gate is controlled 
by the four voltage-sensing domains (VSD) that consist of the S1–S4 segments. Upon changes in the 
membrane potential, the positively charged residues on the S4 segment (gating charges) move across the 
plasma membrane generating a transient ‘gating current’ (IG)7,8. In the generally accepted gating scheme 
for Shaker-type Kv channels, the four VSDs move in a largely independent way from their inward facing 
rested state to their outward facing activated configuration9–11. This transition(s) carries approximately 
90% of the total gating charge but does not open the channel gate. Once all four VSDs have reached their 
activated state, channel gate opening proceeds in a subunit-concerted manner which is accompanied by 
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moving the last 10% of the gating charge12–14. Furthermore, channel gate opening stabilizes the VSD in 
its outward facing activated state and is manifested in slower VSD deactivation kinetics10,15.
Analyzing the sensitivity of different Kv channels to alkanols revealed an inter-species difference 
wherein the Kv channels from the fruit fly drosophila melanogaster displayed a higher affinity than their 
mammalian orthologs16,17. The higher alkanol sensitivity of the drosophila Shaw2 channel could be trans-
planted onto its mammalian Kv3.4 counterpart by exchanging the S4–S5 linker18. Site-specific residue 
substitution studies further supported that the S4–S5 linker forms with possible contribution of S6c a 
key determinant in channel inhibition by alkanols4,19–22. To elucidate alkanols’ mechanism of action, we 
performed detailed gating current analysis of the drosophila Shaker Kv channel and show that 1-Butanol 
(1-BuOH) and 1-Hexanol (1-HeOH) stabilize the channel in the non-conducting activated state, which 
results in a 10% reduction in gating charge movement and an accelerated VSD deactivation. Although 
this behavior was reminiscent to the effect of 4-aminopyridine (4-AP)14,23, alkanols act via a distinct 
binding site for preventing the Shaker Kv channel of passing the final subunit-concerted transition lead-
ing to channel opening.
Results
Concentration-dependent inhibition of Shaker Kv channel by 1-BuOH and 1-HeOH. The 
drosophila Shaw2 Kv channel was identified to display the highest sensitivity for alkanols and has there-
fore been the subject to study the mechanism of their action4,16,19,21. The drosophila Shaker Kv channel was 
also inhibited by alkanols but compared to Shaw2 it displayed a lower sensitivity17. Since its cloning, the 
Shaker Kv channel became rapidly the prototypical Kv channel for structure-function studies and most 
of the current knowledge on the operation of the VSDs, the electromechanical coupling and the channel 
gate is based on studies in this channel. Thus, despite its lower sensitivity, the available knowledge on the 
gating mechanism is an advantage of the Shaker Kv channel for determining the mechanism of channel 
inhibition by alkanols.
Alkanols are classified in short chain (up to 5 carbonyls, C1 to C5) or long chain (C6 – C22) 1-alcohols24. 
In this study, 1-BuOH and 1-HeOH were chosen as representative compounds of a short and long chain 
alkanol. Their effect was tested on both the ionic (IK) and gating (IG) currents of the fast (N-type) inacti-
vation removed Shaker-IR channel. At the IK level, Shaker-IR was inhibited by both 1-BuOH and 1-HeOH 
in a concentration-dependent manner (Fig.  1A–C). For 1-BuOH a concentration-response curve was 
obtained with an IC50 value of 51.8 ± 5.9 mM (n = 5) and a Hill coefficient of 0.92 ± 0.04 (Fig.  1D). 
Figure 1. Inhibition of Shaker-IR by 1-BuOH and 1-HeOH. (A) Representative IK recordings of Shaker-IR 
in control condition (left) and in presence of 100 mM 1-BuOH (right) elicited by applying depolarization 
steps from a -80 mV holding potential (pulse protocols are shown on top). (B) IK recordings of Shaker-IR 
obtained in control conditions (left) and in presence of 3 mM 1-HeOH (right). (C) Steady-state IK recordings 
(elicited with a voltage step from -80 mV to 0 mV) upon wash-in of different concentrations of 1-BuOH 
(left) and 1-HeOH (right). Establishment of channel inhibition was monitored by repetitive pulsing to 0 mV. 
(D) Concentration-response curves obtained by plotting the normalized steady-state IK amplitude at 0 mV, 
determined from IK recordings as shown in panel C, as a function of 1-BuOH (circles, n = 5) or 1-HeOH 
(triangles, n = 7) concentration. Solid lines represent the average fit with a Hill function.
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1-HeOH had a slightly higher affinity and yielded a concentration-response curve with an IC50 value of 
2.7 ± 0.2 mM (n = 7) and a Hill coefficient of 1.13 ± 0.22 (Fig.  1D). Monitoring the development of IK 
inhibition and analyzing the remaining steady-state IK amplitude upon application of 50 mM 1-BuOH 
or 3 mM 1-HeOH (IC50 concentrations) indicated that: (1) the IK inhibition developed rapidly and was 
fully reversible upon wash-out of both alkanols, and (2) both alkanols did not induce major alterations 
in the voltage dependence of channel opening nor the time constants of channel activation (τ IKac) and 
deactivation (τ IKdeac) (Fig. 2 and Table 1). An apparent channel inactivation behavior or rising phase in 
the deactivating (IKdeac) tail current (i.e. a hooked tail), which are typical hallmarks for an open channel 
blocker, were not observed (Fig. 1A–C). Thus, 1-BuOH and 1-HeOH inhibited the IK amplitude without 
affecting the kinetics, and both compounds achieved this through a mechanism most likely different 
from open channel block, as proposed previously4.
1-BuOH and 1-HeOH accelerate VSD deactivation and immobilize approximately 10% of the 
gating charge. The IK measurements only report on the final opening of the channel gate, which is an 
end state in the activation pathway from closed to open. From IG analysis it has been reported that the 
VSD traverses at least one non-conducting activated state before the channel gate opens. Channel gate 
opening subsequently slows down VSD deactivation10,15, which can be visualized by gradually prolong-
ing the duration of the depolarizing pre-pulse (Fig. 3A). Thus, to assess whether 1-BuOH and 1-HeOH 
affect transitions early in the activation pathway, i.e. before the channel gate opened, we tested the 
effect of both compounds on the IG recordings of the non-conducting Shaker-IR pore mutant W434F25. 
During wash-in of both 1-BuOH and 1-HeOH we noted a concentration-dependent acceleration of the 
deactivating (IGdeac) gating currents (Fig. 3B,C). Plotting the time constant of VSD deactivation (τIGdeac, 
obtained by fitting the decaying phase of IGdeac) as a function of 1-BuOH or 1-HeOH concentration 
yielded concentration-response curves with IC50 values of 67 ± 1 mM (n = 10) and 3.0 ± 0.4 mM (n = 6), 
and Hill coefficients of 1.3 ± 0.4 and 1.6 ± 0.3, respectively (Fig. 3D).
To examine whether this acceleration in τ IGdeac was associated with a reduction in gating charge 
movement, we integrated the activating (IGac) gating currents (elicited during the depolarizing test pulse) 
Figure 2. Alkanols inhibited IK without affecting the kinetics. (A) Monitoring the inhibition in IK during 
application of 50 mM 1-BuOH (top panel) or 3 mM 1-HeOH (bottom panel) indicated that the IK inhibition 
developed rapidly with a time constant of 5.2 ± 1.2 s (n = 8) and 3.7 ± 0.7 s (n = 9) for 1-BuOH and 
1-HeOH respectively. The IK inhibition was fully reversible upon wash-out of both alkanols and the current 
recovery was relatively fast yielding time constants of 7.6 ± 2.1 s (n = 8) and 4.8 ± 1.7 s (n = 9 ) for 1-BuOH 
and 1-HeOH respectively. (B) Normalized peak current versus voltage relationships, obtained from pulse 
protocols shown in Fig. 1A, in control conditions (open symbols) and presence of 50 mM 1-BuOH (top 
panel, n = 5) or 3 mM 1-HeOH (bottom panel, n = 6). (C) Normalized conduction versus voltage GV curves 
in control conditions (open symbols) and presence of 50 mM 1-BuOH (top panel, n = 5) or 3 mM 1-HeOH 
(bottom panel, n = 6). Solid lines represent the average fit with a Boltzmann equation (V1/2 and slope factor 
values are provided in Table 1). (D) Time constants of IK activation (τ IKac) and deactivation (τ IKdeac) in 
control conditions (open symbols) and in presence of 50 mM 1-BuOH (top panel, n = 7) or 3 mM 1-HeOH 
(bottom panel, n = 8).
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after reaching steady-state modification of the τ IGdeac kinetics. This analysis indicated that there was an 
alkanol-dependent reduction in gating charge movement concomitantly with the acceleration in τ IGdeac. The 
reduction in total gating charge as a function of alkanol concentration yielded for 1-BuOH and 1-HeOH 
concentration-response curves with IC50 values of 88 ± 2 mM (n = 10) and 13.8 ± 1.6 mM (n = 6), and 
Hill coefficients of 1.5 ± 0.2 and 1.5 ± 0.2, respectively (Fig. 3E). Based on these concentration-response 
curves, the maximal reduction in charge movement amounted to approximately 10% and 12% upon 
application of 300 mM 1-BuOH and 30 mM 1-HeOH, respectively.
To determine the kinetics and voltage dependence of VSD activation, we applied incremental depolar-
izing voltage steps starting from a constant hyperpolarized initial voltage (activation protocol, Fig. 4A). 
To characterize VSD deactivation adequately, a deactivation pulse protocol was used (Fig. 4B). Integrating 
the IGac recordings, obtained in control conditions and after steady-state 1-BuOH and 1-HeOH modifica-
tion, yielded charge vs. voltage QV curves (Fig. 4C). Interestingly, the QV curves determined in presence 
of 1-BuOH or 1-HeOH displayed V1/2 and slope factor values similar as in control condition (Table 1). 
This indicated that neither alkanol affected the voltage dependence of the remaining gating charge move-
ment. As noted during the wash-in protocol (Fig. 3B,C), both alkanols accelerated τ IGdeac without mark-
edly altering the IGac kinetics (τ IGac, Fig. 4D,E). Thus, both alkanols accelerated τ IGdeac and immobilized 
approximately 10% of the gating charge movement but did not affect the voltage dependence of the 
early VSD movements. These observations indicated that in presence of 1-BuOH or 1-HeOH the Shaker 
channel is able to reach the non-conducting activated state but it cannot pass the subunit-cooperative 
step leading to channel gate opening. Accordingly, the τ IGdeac values in presence of saturating alkanol 
concentrations should corresponded to τ IGdeac in control conditions when the activating pre-pulse is 
very short and channels only reach the non-conducting activated state. In control conditions τ IGdeac 
amounted at −120 mV to 0.32 ± 0.03 ms (n = 6) upon a brief 0.5 ms depolarization, determined from 
pulse protocols shown in Fig. 3A. In presence of 300 mM 1-BuOH or 30 mM 1-HeOH τ IGdeac at −120 mV 
were 0.48 ± 0.08 ms (n = 4) and 0.53 ± 0.10 ms (n = 4) respectively (Fig. 4D,E), which are indeed similar 
to the value in control conditions.
1-alkanols and 4-AP have different binding sites but immobilize the same gating charge com-
ponent. The impact of 1-BuOH and 1-HeOH on the IG recordings of the Shaker-IR-W434F channel 
GV curve (voltage dependence of gate opening)
Shaker-IR V1/2 (mV) k (mV) n
control conditions − 27.0 ± 1.3 5.6 ± 0.7 11
1-BuOH (50 mM) − 28.5 ± 2.3  5.1 ± 0.7 5
1-HeOH (3 mM) − 25.4 ± 1.2  7.5 ± 0.9 6
Shaker-IR-P475A V1/2 (mV) k (mV) n
control conditions 74 ± 1 12.3 ± 0.7 8
1-BuOH (300 mM) 50 ± 1  6.8 ± 0.7 4
 100 mM 62 ± 1 9.6 ± 0.4 8
1-HeOH (30 mM) 49 ± 1 6.6 ± 0.6 5
 10 mM 64 ± 1 10.7 ± 0.6 5
QV curve (voltage dependence of VSD movement)
Shaker-IR-W434F V1/2 (mV) k (mV) n
control conditions − 33.2 ± 5.4 − 11.6 ± 2.0 10
1-BuOH (300 mM) − 32.4 ± 3.4 − 12.5 ± 1.7 5
1-HeOH (30 mM) − 31.4 ± 0.9 − 10.1 ± 0.8 4
1st comp 2nd comp
Shaker-IR-W434F-P475A V1/2 (mV) k (mV) V1/2 (mV) k (mV) n
control conditions − 33.1 ± 0.8 14.5 ± 0.8 59.6 ± 2.7 10.1 ± 2.4 8
1-BuOH (300 mM) − 39.2 ± 1.4 16.2 ± 1.2 52.2 ± 1.2 9.1 ± 1.1 5
1-HeOH (30 mM) − 35.3 ± 1.5 16.9 ± 1.5 50.2 ± 1.1 3.6 ± 1.4 4
Table 1.  Midpoint (V1/2) and slope factor (k) values of the GV and QV curves of Shaker-IR, Shaker-
IR-P475, and their non-conducting W434F variants.
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was reminiscent of the effect of 4-AP that prevents the channels from passing the late subunit-cooperative 
step of channel gate opening, resulting in a similar 10% reduction in gating charge movement14. To assess 
if 4-AP and 1-BuOH immobilized the same gating charge component, we determined the reduction in 
gating charge movement using a mixture of 1 mM 4-AP and 300 mM 1-BuOH, which for both com-
pounds are saturating concentrations. First, we applied 1 mM 4-AP that resulted in an approximately 10% 
loss of gating charge movement and an acceleration of τ IGdeac, as has been described before14,23. After 
establishing a steady-state 4-AP effect, we applied 300 mM 1-BuOH in the continued presence of 1 mM 
4-AP. The addition of 1-BuOH did not result in an extra reduction of gating charge movement or further 
acceleration of the IGdeac kinetics (Fig. 5). This indicated that both compounds affected the same gating 
charge component and further supported that alkanols stabilize the channel in the non-conducting acti-
vated state similar to 4-AP.
Although alkanols and 4-AP exert a similar effect at the gating current level, they may act through 
different binding sites. Whereas the binding site of 4-AP partially overlaps with that of internal pore 
Figure 3. Impact of alkanols on IG recordings of Shaker-IR-W434F. (A) Representative IG recordings 
of Shaker-IR-W434F recorded in control conditions with the pulse protocol shown on top. Note that 
prolonging the depolarization at +20 mV gradually slowed down IGdeac upon repolarization to −120 mV.  
(B) Superposition of Shaker-IR-W434F steady-state IG recordings in control condition (gray) and in presence 
of 100 mM (dark gray) and 300 mM (black) 1-BuOH. Inset shows a scale up view of IGac. Note the gradual 
acceleration in IGdeac upon application of higher concentrations of 1-BuOH. (C) Superposition of steady-state 
IG recordings in control condition (gray) and in presence of 3 mM (dark gray) and 30 mM (black) 1-HeOH. 
(D) Concentration-response curves obtained by plotting the weighted τ IGdeac at −90 mV (obtained from IGdeac 
recordings shown in panel A and B) as a function of 1-BuOH (circles, n = 10) or 1-HeOH (triangles, n = 6) 
concentration. (E) Concentration-response curves obtained by plotting the normalized charge movement, 
which was determined by integrating the steady-state IGac recordings and normalizing the calculated charge 
to the total charge moved in control condition, as a function of alkanol concentration.
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Figure 4. Biophysical properties of Shaker-IR-W434F upon alkanol application. (A) Representative 
IGac recordings of Shaker-IR-W434F in control condition (left) and in presence of 300 mM 1-BuOH (right) 
elicited using the pulse protocols shown on top. (B) Representative IGdeac recordings elicited with the 
deactivation pulse protocols shown on top; in control conditions (left) and in presence of 100 mM 1-BuOH 
(right). Inter-sweep holding potential was −90 mV and the depolarizing pre- and post-pulse to 0 mV were 
15 ms in duration. (C) Charge vs. voltage QV curves in control condition (white circles, n = 10) and in 
presence of 300 mM 1-BuOH (black circles, n = 5) or 30 mM 1-HeOH (black triangles, n = 4) were created 
by plotting the normalized charge (obtained from integrating IGac recordings from pulse protocols shown 
in panel A) as a function of voltage. Curves shown are the average fit to a Boltzmann equation. (D) Time 
constants of VSD activation (τ IGac) in control condition (white diamonds, n = 8) and in presence of 100 mM 
(gray diamonds, n = 3) or 300 mM (black diamonds, n = 5) 1-BuOH. For VSD deactivation the weighted 
τ IGdeac kinetics are shown. Note the gradual acceleration in τ IGdeac between control (white circles), 100 mM 
1-BuOH (gray circles) and 300 mM 1-BuOH (black circles). (E) Panel shows the voltage-dependent τ IGac 
kinetics in control condition (white squares, n = 7) and in presence of 10 mM (gray squares, n = 3) or 30 mM 
(black squares, n = 4) 1-HeOH. Similar to 1-BuOH the τ IGdeac kinetics accelerated in presence of 10 mM 
(gray triangles, n = 3) and 30 mM 1-HeOH (black triangles, n = 4), control conditions (white triangles).
Figure 5. 1-BuOH and 4-AP immobilize the same gating charge component. (A) Superposition of 
steady-state IGdeac recordings of Shaker-IR-W434F, elicited during a repolarizing step to -120 mV upon a 
50 ms depolarization at 0 mV, in control condition (light gray), in presence of 1 mM 4-AP (dark gray), and 
in presence of 1 mM 4-AP plus 300 mM 1-BuOH (black). Note that the mixture of 4-AP plus 1-BuOH did 
not result in an extra acceleration of IGdeac decay or an extra reduction in gating charge movement. (B) Panel 
shows τ IGac and τ IGdeac in control condition (white circles, n = 6), in presence of 4-AP (dark gray squares, 
n = 5), and 4-AP plus 1-BuOH mixture (black circles, n = 6). Both drug conditions resulted in a similar 
acceleration of τ IGdeac without affecting τ IGac markedly.
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blockers26,27, alkanols have been proposed to target the electromechanical coupling that is located outside 
the K+ pore. To test whether 4-AP and 1-BuOH have structurally different binding sites, we performed 
drug competition experiments using IC50 concentrations of 4-AP (30 μ M) and 1-BuOH (50 mM). After 
establishing approximately 50% steady-state IK inhibition with 4-AP, we applied a mixture of 30 μ M 4-AP 
and 50 mM 1-BuOH. This mixture resulted in 78.7 ± 4.1% (n = 7) inhibition of IK (Fig. 6), thus yielding 
an additional inhibition of 29% in IK amplitude compared to each compound separately.
To evaluate whether 4-AP and 1-BuOH competed, the expected inhibition of the mixture was calcu-
lated using a syntopic (both compounds compete) or an allotopic (no competition) model28. Using an 
allotopic model and the experimentally determined inhibition of each compound separately, the pre-
dicted inhibition of the mixture was 81.4 ± 2.4% (n = 7). With a syntopic model the predicted inhibi-
tion was 73.4 ± 2.8% (n = 7). Because the experimentally determined inhibition (78.7%) differed only 
statistically (p < 0.05) from the predicted value of the syntopic model (Fig. 6), our data matched best an 
allotopic model indicating that there was no competition between both compounds.
1-BuOH and 1-HeOH activate the Shaker-IR-P475A mutant by accelerating channel 
 opening. A previous study reported that substituting a highly conserved proline residue in the S6c of 
the Shaw2 channel (the second proline of a highly conserved PXP motif within the S6c of Kv channels) 
by a neutral amino acid such as alanine inverted the effect of the alkanols22. Thus, instead of inhibiting 
the channel mutant, application of alkanols potentiated the current amplitude. An alanine substitution 
for the corresponding proline (P475) in Shaker-IR shifted the threshold for channel opening towards 
more depolarized potentials by affecting the late step(s) of channel gate opening while leaving earlier 
VSD transitions unaffected29. Consequently, the Shaker-IR-P475A mutant displays slow IKac kinetics that 
is only weakly voltage-dependent.
Applying 1-BuOH or 1-HeOH to the Shaker-IR-P475A mutant resulted in a concentration-dependent 
increase in IK and an acceleration of τ IKac (Fig. 7A,B), which is in agreement with previous data obtained 
in the Shaw2 channel22. With higher concentrations of 1-BuOH or 1-HeOH the typical conduction ver-
sus voltage GV curves, which were determined from normalizing the deactivation tail current of activa-
tion protocols (Fig. 8A), appeared to become steeper and to shift slightly towards more hyperpolarized 
potentials (Fig. 8B, Table 1). However, concomitantly with the accelerated τ IKac kinetics, also the inacti-
vation process became more pronounced and the peak IK amplitude started to decrease at higher alkanol 
concentrations (Fig. 7A,B). Therefore, the small hyperpolarizing shift and steepening of the GV curves 
could be an apparent effect due to the accelerated channel inactivation. To test this possibility, we deter-
mined the normalized conduction G from the peak outward currents using the Goldman-Hodgkin-Katz 
current equation. The GV curves obtained with this approach, which should be less sensitive to inacti-
vation, were in presence of alkanols similar to those in control conditions (Fig. 8B). Thus, although both 
compounds resulted in IK activation, neither 1-BuOH nor 1-HeOH affected the voltage dependence of 
channel opening substantially. To evaluate if the pronounced channel inactivation behavior reflects in 
fact open channel block, we examined IKdeac more closely. In contrast to what is expected with open chan-
nel block, the IKdeac recordings did not cross nor did they display a noticeable hook (Fig. 7A,B). In fact, 
the τ IKdeac kinetics accelerated markedly which suggested that also the accelerated channel inactivation 
was due to gating modification. All these effects were fully reversible upon wash-out of both alkanols.
The IKac of Shaker-IR-P475A displayed two components and was best approximated with a double 
exponential function yielding a fast and a slow τ IKac component29. However, the fast component con-
tributed only marginally to the overall IK amplitude and the weighted τIKac kinetics approximated the 
value of the slow component in control condition (Fig.  8C). 1-BuOH or 1-HeOH accelerated channel 
Figure 6. 1-BuOH and 4-AP do not compete for inhibiting Shaker-IR. (A) Sequentially recorded IK of 
Shaker-IR in control condition and after steady-state inhibition by 50 mM 1-BuOH and 30 μ M 4-AP. Finally, 
instead of washing the 30 μ M 4-AP out, a mixture of 30 μ M 4-AP plus 50 mM 1-BuOH was added and the 
amount of IK inhibition was determined. (B) Bar chart shows the average reduction in IK ± S.E.M. (n = 7) 
after applying 50 mM 1-BuOH, 30 μ M 4-AP and the mixture of both compounds (30 μ M 4-AP plus 50 mM 
1-BuOH). The percentage of IK inhibition was calculated by normalizing the steady-state IK in presence of 
drug to the IK amplitude in control conditions. The expected reduction in IK for an allotopic and syntopic 
model was calculated as described in Material and Methods. Note, the experimentally obtained value 
differed only statistically from the predicted value of a syntopic model (*p < 0.05).
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opening markedly but approximating the IKac currents with a double exponential function indicated 
that the time constants of both the fast and slow component were similar to those obtained in control 
condition. However, the contribution of the fast component in the total current amplitude increased as 
a function of alkanol concentration (Fig. 8C). Consequently, the weighted τ IKac accelerated with increas-
ing alkanol concentration (Fig. 8D,E). Similar to IKac, the weighted τ IKdeac kinetics, obtained from fitting 
IKdeac with a double exponential function, accelerated in an alkanol concentration-dependent manner 
(Fig.  8D,E). Plotting the weighted τ IKac as a function of 1-BuOH or 1-HeOH concentration yielded 
concentration-response curves with IC50 values of 58.8 ± 3.0 mM (n = 5) and 4.6 ± 0.8 mM (n = 4), and 
Hill coefficients of 1.5 ± 0.4 and 1.3 ± 0.3, respectively (Fig. 8F). This indicated that the alanine substi-
tution for P475 in S6c did not affect the affinity for alkanols, suggesting that the conformation of the 
binding site remained intact.
1-BuOH and 1-HeOH did not affect the VSD movements of the P475A mutant. Since the 
Shaker-IR-P475A mutant did not affect the early VSD movements, the QV curve was split and dis-
played two gating charge components whereby the late one corresponded with the voltage dependence 
of channel gate opening29. Analyzing the gating currents of Shaker-IR-W434F-P475A in presence of 
300 mM 1-BuOH or 30 mM 1-HeOH indicated that the voltage dependence of neither the early nor 
the late gating charge component was affected by 1-BuOH or 1-HeOH (Fig.  9 and Table  1). This was 
in agreement with the absence of an obvious shift in the threshold of channel opening (Fig. 8B). Also 
the IGac time constants, which in Shaker-IR-W434F-P475A report directly on the kinetics of the early 
VSD movements29, were unaffected by 1-BuOH or 1-HeOH. These IG data confirmed that 1-BuOH and 
1-HeOH did not affect the voltage-dependent transitions of the Shaker-IR-P475A mutant but facilitated 
a late largely voltage-independent transition in the activation pathway, a transition that is compromised 
by the P475A mutation.
Discussion
1-BuOH and 1-HeOH inhibited the Shaker–IR channel in a concentration-dependent manner without 
displaying the classic hallmarks of an open channel blocker. Therefore, alkanols appear to act as gating 
modifiers that stabilize the channels in a non-conducting state4. To elucidate which state is stabilized by 
alkanols, we determined the impact of 1-BuOH and 1-HeOH on the IG recordings of Shaker-IR-W434F. 
Both alkanols caused a concentration-dependent reduction in gating charge movement associated with 
accelerated VSD deactivation (Fig.  3). This data indicated that alkanols interfere with the transition 
from the non-conducting activated conformation to full channel gate opening, which occurs in a highly 
subunit-cooperative (concerted) manner. Consequently, the reduction in either IK or gating charge move-
ment as a function of alkanol concentration yielded concentration-response curves with similar IC50 
values and Hill coefficients (Figs 1,3). Since alkanols have been proposed to operate via the S4-S5 linker18, 
there are 4 potential alkanol binding sites on the channel that appear to operate largely independently 
(Hill coefficients of approximately 1). As they interfere with a subunit-cooperative transition, binding of a 
single alkanol molecule (occupying only one out of four binding sites) can be sufficient to prevent chan-
nel gate opening and losing about 10% of the gating charge movement. Accordingly, a previous study, 
which used concatemeric constructs, showed that channels with less than four high affinity binding sites 
(e.g. only 2) were still inhibited by alkanols4. Thus, we propose that alkanols inhibit Shaker-IR currents 
by preventing the channels of passing the final concerted step in the activation sequence that opens the 
channel gate. Therefore, the ionic current data analysis represented in figure 2 reports on the channels 
Figure 7. Alkanol-dependent activation of Shaker-IR-P475A. (A) Steady-state IK recordings of Shaker-
IR-P475A in control condition (black), 100 mM (blue), and 300 mM (red) 1-BuOH elicited using the pulse 
protocol shown on top. (B) Steady-state IK recordings obtained in control condition (black), 10 mM (blue) 
and 30 mM 1-HeOH (red). In presence of alkanols the currents activated markedly faster and current 
inactivation was more pronounced. Insets show scale up views of the deactivating (IKdeac) tail currents.
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that were free of alkanols which explains why both the normalized GV curves (Fig. 2C) and the kinetics 
(Fig. 2D) in presence of alkanols were similar to control conditions.
The impact of 1-BuOH and 1-HeOH on Shaker’s gating charge movement was reminiscent to that 
of the well-characterized drug 4-AP14, and both compounds stabilize the Shaker Kv channel in the 
non-conducting activated state. However, both compounds achieve this by acting via distinct binding 
sites (Fig.  6). Whereas the binding determinants for 4-AP, including those for guanidine compounds 
that possibly work in a similar manner30, reside within S6c31,32, alkanols are suggested to distort the 
coupling between the S4-S5 linker and S6c33. The observation that alkanols rescued partly the kinetics 
of the Shaker-IR-P475A mutant, favors the idea that alkanols alter the conformation of the S4–S5 linker 
and/or S6c without disrupting their communication completely. By altering the conformation of the 
Figure 8. Biophysical properties of Shaker-IR-P475A upon alkanol application. (A) Representative IKac 
recordings of Shaker-IR-P475A in control conditions, 100 mM 1-BuOH and 10 mM 1-HeOH, elicited using 
the pulse protocol shown on top. (B) Conduction vs. voltage GV curves of Shaker-IR-P475A in control 
conditions (white circles), 100 mM 1-BuOH (blue circles), 300 mM 1-BuOH (red cricles), 10 mM 1-HeOH 
(blue triangles), and 30 mM 1-HeOH (red triangles). GV curves displayed in the left panel were obtained 
by normalizing tail current amplitudes. Solid lines represent the average fit with a Boltzmann equation 
(V1/2 and slope factor values are provided in Table 1). Right panel displays the GV curves determined 
from analyzing the peak outward currents. (C) Panels from left to right show the τ IKac values of Shaker-
IR-P475A upon increasing 1-BuOH concentrations with the left most panel showing the values in control 
conditions. The fast and slow τ IKac components are represented with open symbols and the weighted τ IKac 
with filled symbols. Note that the contribution of the fast τ IKac component increased upon higher 1-BuOH 
concentrations; compare weighted τ IKac values in 30 mM (yellow symbols) and 100 mM (blue symbols). 
In presence of 300 mM 1-BuOH (red symbols) only the fast component could be resolved and IKac was 
approximated with a single exponential function. (D) Plot shows the weighted τ IKac and τ IKdeac values in 
control conditions (white) and in presence of 10 mM (gray, n = 4), 30 mM (yellow, n = 5), 100 mM (blue, 
n = 8), and 300 mM (red, n = 4) 1-BuOH. (E) Plot shows the effect of 1 mM (gray, n = 7), 3 mM (yellow, 
n = 9), 10 mM (blue, n = 5), and 30 mM (red, n = 5) 1-HeOH on the weighted τ IKac and τ IKdeac kinetics. (F) 
Concentration-response curves obtained by plotting the weighted τ IKac at +100 mV as a function of 1-BuOH 
(black circles, n = 10) and 1-HeOH (gray triangles, n = 6) concentration. Solid lines represent the fit with a 
Hill equation.
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S4-S5 linker and/or S6c, the electromechanical coupling is compromised as its operation relies on a cor-
rect positioning of both segments with respect to each other34.
Mutations that affect the communication between the VSD and the channel gate might therefore alter 
the alkanol effect, as is the case in Shaker-IR-P475A. Apparently, 1-BuOH and 1-HeOH did not shift the 
voltage dependence of the late gating charge component in Shaker-IR-P475A (Fig. 9), which is expected 
if the mutation was only to affect the equilibrium constant of the transition from the non-conducting 
activated to the open state. Therefore, the structural consequences of the P475A mutation should be 
more severe and the Shaker-IR-P475A mutant displayed, accordingly, a biphasic current activation that 
in absence of alkanols is dominated by the slow component. We propose that alkanol binding to the 
Shaker-IR-P475A channel alters the conformation of the S4-S5 linker and/or its communication with S6c 
(as it does in WT Shaker-IR), and in doing so it coincidentally restores the conformation of the S6c channel 
gate that is compromised by the mutation. Alkanols then act as activators of the Shaker-IR-P475A mutant 
by yielding IK current activation that is dominated by the fast component (Fig. 8C–E), thus accelerating 
a late largely voltage-independent transition of channel gate opening. Notably, the effect of both 1-BuOH 
and 1-HeOH on the Shaker-IR-P475A mutant was comparable to the behavior of poly-unsaturated-fatty 
acids (PUFAs): accelerating channel opening followed by more pronounced channel inactivation at higher 
concentrations (Fig. 7A,B). PUFAs have been shown to alter the kinetics of Kv channels leading to current 
activation or current inhibition, in part by accelerating the inactivation process35. At low concentrations 
several PUFAs act as channel activators but at higher concentrations they result in channel inhibition36–38. 
Whereas their activating property is ascribed to their ability to shift the voltage dependence of channel 
opening towards more hyperpolarized potentials and to facilitate the late subunit-concerted transition of 
channel opening39,40, their molecular mechanism to induce channel inhibition is still debated41. Whereas 
alkanols most likely target the S4-S5 linker of Kv channels33, PUFAs supposedly exert their effect through 
the VSD39,40, although a role for the S4-S5 linker has been suggested42.
Alkanols and 4-AP immobilize the same VSD movement(s) in the Shaker-IR channel (Fig.  5), but 
both compounds achieve this via distinct drug binding sites (Fig. 6) and a different mechanism of action. 
This conclusion is further supported by the observation that the mutant Shaker-IR-P475A is activated by 
alkanols (Figs 7,8) but is insensitive to 4-AP29. The presence of other (possibly overlapping) intracellular 
or lipid-accessible binding sites for gating modifying compounds is supported by: (1) the finding that the 
Figure 9. Alkanols did not affect the IG behavior of Shaker-IR-W434F-P475A. (A) Representative 
IG recordings of Shaker-IR-W434F-P475A recorded in control condition (left recordings) and after 
approximately 10 minutes wash-in of 300 mM 1-BuOH (right recordings), elicited with the pulse protocols 
shown on top. Insets show scale up views of IGac and IGdeac respectively. (B) Representative IG recordings of 
Shaker-IR-W434F-P475A in presence of 30 mM 1-HeOH. (C) QV curves of Shaker-IR-W434F-P475A in 
control conditions (white circles) and presence of 300 mM 1-BuOH (black circles, n = 5) or 30 mM 1-HeOH 
(gray triangles, n = 4). (D) τ IGac (gray circles) and τ IGdeac (black circles) kinetics of Shaker-IR-W434F-P475A 
in presence of 300 mM 1-BuOH, which were similar to the kinetics in control condition (white circles). (E) 
Similar to 1-BuOH, 30 mM 1-HeOH did not affect the τ IGac (gray triangles) or the τ IGdeac (black triangles) 
kinetics compared to control condition (white triangles).
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gating modifier toxin gambierol occupies a lipid exposed S5-S6 crevice outside the K+ pore43, a binding 
site which is most likely shared by psora compounds44 and (2) the observation that ruthenium complexes 
uncouple VSD movement from channel gate opening but in contrast to alkanols they immobilize about 
50% of the gating charge45. Furthermore, the binding site for the volatile anesthetic halothane has been 
shown to overlap with that of alkanols21, and both isoflurane and servoflurane, which belong to the same 
class of halogenated general anesthetics, potentiate Kv channels instead of inhibiting them46–48.
The intoxicating and sedating effects of exposure to high alkanol concentrations are well described 
and ion channels (including Kv channels) do most likely form one of their molecular targets. We provide 
a mechanistic basis for understanding their effect on Kv channels and show that 1-BuOH and 1-HeOH 
interfere directly with the gating apparatus of the Shaker–IR Kv channel. They inhibit Shaker-IR by stabiliz-
ing the non-conducting activated state preventing the channels from passing the final subunit-concerted 
transition leading to channel gate opening. They achieve this through a unique gating modifying mech-
anism different from that of 4-AP. Our findings strengthen the idea that there exist different intracellular 
drug binding sites that via distinct mechanisms of action exert a similar gating modifying effect; this 
opens new possibilities for designing modulators of Kv channels.
Methods
Molecular Biology. The N-terminal deletion Δ 6–46 Shaker clone (Shaker-IR), which removes fast 
inactivation49, was used in this study. The W434F mutation, which yields a non-conducting Shaker-IR-
W434F channel25, and the P475A mutation were introduced as described previously29. All channel con-
structs were expressed using a pGW1 expression vector. The plasmid that codes for the green fluorescent 
protein, used to identify transfected cells, was purchased from Clontech (Palo Alto, CA, USA). Plasmid 
DNA for mammalian expression was obtained by amplification in XL2 Bluescript cells (Stratagene), 
and afterwards isolated using the endotoxin-free Maxiprep kit (Macherey-Nagel, Düren, Germany). The 
cDNA concentration was determined by UV absorption.
Cell culture. HEK293 cells were cultured in Modified Eagle’s Medium (MEM) supplemented with 
10% fetal bovine serum, 1% penicillin/streptomycin and 1% non-essential amino acids (Invitrogen, 
Carlsbad, CA, USA). Cells were transiently transfected with the appropriate channel DNA plasmids using 
polyethyleneimine that was purchased from Sigma-Aldrich (St Louis, MO, USA), details of procedure 
was described previously29.
Electrophysiology. Whole-cell ionic IK or gating IG current measurements were done at room 
temperature (20 to 23 °C) using an Axopatch-200B amplifier and the recordings were digitized with a 
Digidata-1200 A acquisition system (Molecular Devices, Sunnyvale, CA, USA). Both IK and IG record-
ings were digitized at 10 kHz sampling rate after passing a 5 KHz Bessel low-pass filter. Command volt-
ages and data storage were controlled with pClamp10 software. Patch pipettes were pulled from 1.2 mm 
quick-fill borosilicate glass capillaries (World Precision Instruments, Sarasota, FL, USA) with a P-2000 
puller (Sutter Instrument Co., Novato, CA, USA) and afterwards heat-polished, to have patch pipettes 
with a resistance of approximately 1.5 MOhm determined with the filled pipette in the bath solution.
For IK measurements the cells were constantly superfused with external bath solution that contained 
(in mM) NaCl 130, KCl 4, CaCl2 1.8, MgCl2 1, HEPES 10, Glucose 10, adjusted to pH 7.35 with NaOH. 
The patch pipettes were filled with internal solution containing (in mM) KCl 110, K4BAPTA 5, K2ATP 
5, MgCl2 1, HEPES 10, adjusted to pH 7.2 with KOH. For IG measurements the monovalent cations 
were replaced with N-methyl-D-glucamine (NMG+). The bath solution contained (in mM) NMG+ 140, 
HEPES 10, Glucose 10, MgCl2 1, CaCl2 1.8, titrated to pH 7.35 with HCl. The pipette solution contained 
(in mM) NMG+ 140, HEPES 10, EGTA 10, MgCl2 1, titrated to pH 7.2 with HCl. Junction potentials 
were zeroed with the filled pipette in the bath solution and experiments were excluded from analysis if 
the voltage error estimate exceeded 5 mV after series resistance compensation. For IG measurements, leak 
currents and remaining capacitive currents were subtracted online using a −P/6 protocol (using a holding 
potential of −95 mV). IK recordings were not leak corrected.
Drug solutions. 1-BuOH and 1-HeOH (Sigma-Aldrich, St. Louis, MO, US) were directly dissolved 
in the external recording solution for either IK or IG measurements. The different test concentrations 
were daily made as both compounds are volatile lowering the effective concentration upon storage. For 
the highest concentration of 1-BuOH tested (300 mM), the osmolarity of the extracellular solution for 
IK or IG recordings increased by approximately 300 mOsm resulting in a total osmolarity of ~640 mOsm. 
Because of the rapid partitioning of alkanols across the plasma membrane, we expected a minor impact 
of this increase in osmolarity. Indeed, the cells tolerated remarkably well the perfusion of the 300 mM 
1-BuOH solution. This was not the case when the cells were perfused with a 600 mOsm extracellular 
solution that contained glucose, which does not easily partition across the plasma membrane, to increase 
osmolarity (data not shown). 4-AP was purchased from Sigma-Aldrich and after dissolving it in the 
external recording solutions the pH was adjusted to 7.35 using HCl. All compounds were applied to the 
cells using a pressurized fast perfusion system equipped with a quartz micromanifold (ALA scientific, 
Farmingdale, NY, USA), allowing rapid exchange of the external solutions.
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Data analysis. Details of pulse protocols used to elicit IK or IG recordings were adjusted to determine 
the biophysical properties of each construct adequately and are shown in the figures or described in 
legends. All the graphs were built using SigmaPlot 11.0 (Systat Software Inc., San Jose, CA, USA). If not 
mentioned otherwise, the conductance vs. voltage (GV) curves were determined from analyzing nor-
malized tail current amplitudes and the charge vs. voltage (QV) curves by integrating the activating IG 
currents. The QV and GV curves of Shaker-IR were fitted with a Boltzmann equation: y = 1/{1 + exp[− 
(V − V1/2)/k]}, where V represents the applied voltage, V1/2 the midpoint potential at which 50% of 
the total charge has moved or half of the channels have opened, and k the slope factor. For the P475A 
mutant the GV curve was also approximated with a single Boltzmann equation whereas its QV curve 
was approximated with the sum of two Boltzmann distributions. Activation IK kinetics (τ IKac) were deter-
mined by approximating the rise in IKac with a single or double exponential function. Deactivation IK 
kinetics (τ IKdeac) were obtained from single or double exponential fits to the IKdeac decay elicited at various 
repolarizing potentials following a 25 ms depolarizing pre-pulse to + 20 mV that activated the channels. 
When a double exponential function was used to determine the fast (τ fast) and slow (τ slow) component of 
the τ IKac and τ IKdeac kinetics, the weighted time constants (τ W) were calculated based on the amplitude 
of each component: τ W = (Afast/(Afast + Aslow)) x τ fast + (Aslow/(Afast + Aslow)) x τ slow, with Afast and Aslow 
the amplitude of the fast and slow component respectively. The IG activation and deactivation kinetics 
(τ IGac and τ IGdeac) were determined by fitting the decaying part of IGac and IGdeac with a single exponential 
function. All results are expressed as mean ± S.E.M. with n the number of cells analyzed.
Concentration–response curves (both from IK and IG analysis) were fitted in the program OriginPro 
8 (OriginLab Corp., Northampton, MA, USA) with a Hill equation: Ieffect = Imin + ({Imax − Imin}/{1 + 
([alkanol]/IC50)Hill coefficient}), where [alkanol] is the concentration of 1-BuOH or 1-HeOH and IC50 the 
concentration that induces 50% effect. To test whether 1-BuOH shares a similar and/or overlapping bind-
ing site with 4-AP, we performed competition experiments based on a previously described approach28. 
The method is based on comparing the experimental determined inhibition to the expected level of 
channel inhibition using an allotopic (non-competing) or a syntopic model (competing). Formulas used 
for calculating the expected inhibition in presence of both compounds (INX,Y) according to the allotopic 
and syntopic model were INX,Y = (INX + INY − INXINY) and INX,Y = ((INX + INY − 2INXINY)/(1− INXINY)), 
respectively. INX and INY were the experimentally determined level of channel inhibition induced by each 
compound independently. I.e. INX was the inhibition induced by 1-BuOH and INY the level of inhibition 
induced by 4-AP. A two way analysis of variance (ANOVA) was used to determine the differences of a 
dual inhibition. A post hoc Dunnett’s was used to compare both models.
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